Cancer medicine

Keyphrases

Publications

volume 13, number 9, 2024

Xiaoyan Han, Xincheng Jiang, Jingsong He, Gaofeng Zheng, Yaqin Xiong, Yanling Wen, Yang Yang, Donghua He, Qingxiao Chen, Yi Zhao, Yi Li, Wenjun Wu, Zhen Cai
Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China. Cancer medicine 13 (9) (2024)
Aijun Liu, Hong Yu, Rui Hou, Zunmin Zhu, Jun-Ling Zhuang, Li Bao, Zhenling Li, Lihong Liu, Luoming Hua, Yanping Ma, Da Gao, Arong Jin, Xiaohui Suo, Wei Yang, Yuansong Bai, Rong Fu, Deqiang Zheng, Wenming Chen
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study. Cancer medicine 13 (9) (2024)
Yanlin Chen, Yuhan Chen, Weidong Lin, Lu Fu, Huiyi Liu, Sijia Pu, Haowei Chen, Hong Yi, Yumei Xue
Impact of hyperuricemia and chronic kidney disease on the prevalence and mortality of cardiovascular disease in cancer survivors. Cancer medicine 13 (9) (2024)
Chuang Jiang, Weixing Liu, Zechuan Jin, Ling Lan, Lin Xu, Ao Du, Song Peng, Yong Zeng, Haichuan Wang, Mingheng Liao, Jin Zhou
Construction and validation of "WCH-nomogram" for predicting the prognosis after resection of colorectal liver metastases. Cancer medicine 13 (9) (2024)
Yanlin Chen, Yuhan Chen, Weidong Lin, Lu Fu, Huiyi Liu, Sijia Pu, Haowei Chen, Hong Yi, Yumei Xue
Impact of hyperuricemia and chronic kidney disease on the prevalence and mortality of cardiovascular disease in cancer survivors. Cancer medicine 13 (9) (2024)
Chuang Jiang, Weixing Liu, Zechuan Jin, Ling Lan, Lin Xu, Ao Du, Song Peng, Yong Zeng, Haichuan Wang, Mingheng Liao, Jin Zhou
Construction and validation of "WCH-nomogram" for predicting the prognosis after resection of colorectal liver metastases. Cancer medicine 13 (9) (2024)
Divya Gandra, David H Mulama, David M Foureau, Kimberly Q McKinney, Elizabeth Kim, Kaitlyn Smith, Jason Haw, Abhinav Nagulapally, Giselle L Saulnier Sholler
DFMO inhibition of neuroblastoma tumorigenesis. Cancer medicine 13 (9) (2024)
Ludivine Bertonnier-Brouty, Jonas Andersson, Tuomas Kaprio, Jaana Hagström, Sara Bsharat, Olof Asplund, Gad Hatem, Caj Haglund, Hanna Seppänen, Rashmi B Prasad, Isabella Artner
E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma. Cancer medicine 13 (9) (2024)
Aijun Liu, Hong Yu, Rui Hou, Zunmin Zhu, Jun-Ling Zhuang, Li Bao, Zhenling Li, Lihong Liu, Luoming Hua, Yanping Ma, Da Gao, Arong Jin, Xiaohui Suo, Wei Yang, Yuansong Bai, Rong Fu, Deqiang Zheng, Wenming Chen
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study. Cancer medicine 13 (9) (2024)
Jinliang Ni, Xiaoxiang Yao, Wei Song, Heng Zhang, Houliang Zhang, Yidi Wang, Yifan Zhang, Guangchun Wang, Keyi Wang, Weipu Mao, Bo Peng
Prognostic value of preoperative combined neutrophil, monocyte, and lymphocyte scores in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A retrospective study. Cancer medicine 13 (9) (2024)
Xiaoyan Han, Xincheng Jiang, Jingsong He, Gaofeng Zheng, Yaqin Xiong, Yanling Wen, Yang Yang, Donghua He, Qingxiao Chen, Yi Zhao, Yi Li, Wenjun Wu, Zhen Cai
Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China. Cancer medicine 13 (9) (2024)
Ines Block, Mark Burton, Kristina P Sørensen, Martin J Larsen, Thi T N Do, Martin Bak, Søren Cold, Mads Thomassen, Qihua Tan, Torben A Kruse
Ensemble-based classification using microRNA expression identifies a breast cancer patient subgroup with an ultralow long-term risk of metastases. Cancer medicine 13 (9) (2024)
Yuanyuan Yang, Jiayi Zhan, Xiaosheng Li, Jun Hua, Haike Lei, Xiaoliang Chen
A nomogram to predict the risk of venous thromboembolism in patients with colon cancer in China. Cancer medicine 13 (9) (2024)
Adam Khan, Hassan Khan, Griffin K Hughes, Chase Ladd, Ryan McIntire, Brooke Gardner, Andriana M Peña, Abigail Schoutko, Jordan Tuia, Kirstien Minley, Alyson Haslam, Vinay Prasad, Matt Vassar
Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials. Cancer medicine 13 (9) (2024)
Takayama Koichi, Ai Kojima, Chikara Honda, Masahiro Nakayama, Satomi Kanemata, Toshimitsu Endo, Kei Muro
Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan. Cancer medicine 13 (9) (2024)
Takayama Koichi, Ai Kojima, Chikara Honda, Masahiro Nakayama, Satomi Kanemata, Toshimitsu Endo, Kei Muro
Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan. Cancer medicine 13 (9) (2024)
Lisa Mikesell, Denalee M O'Malley, Rachel T Kurtzman, Jenna Howard, Benjamin Bates, Jennifer R Hemler, Sarah J Fadem, Jeanne M Ferrante, Alicja Bator, Shawna V Hudson, Benjamin F Crabtree
Identifying priority areas to support primary care engagement in breast cancer survivorship care: A Delphi study. Cancer medicine 13 (9) (2024)
Amina Banda, Jenneken Naaldenberg, Aura Timen, Agnies van Eeghen, Geraline Leusink, Maarten Cuypers
Cancer risks related to intellectual disabilities: A systematic review. Cancer medicine 13 (9) (2024)
Takayama Koichi, Ai Kojima, Chikara Honda, Masahiro Nakayama, Satomi Kanemata, Toshimitsu Endo, Kei Muro
Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan. Cancer medicine 13 (9) (2024)
Ludivine Bertonnier-Brouty, Jonas Andersson, Tuomas Kaprio, Jaana Hagström, Sara Bsharat, Olof Asplund, Gad Hatem, Caj Haglund, Hanna Seppänen, Rashmi B Prasad, Isabella Artner
E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma. Cancer medicine 13 (9) (2024)
Divya Gandra, David H Mulama, David M Foureau, Kimberly Q McKinney, Elizabeth Kim, Kaitlyn Smith, Jason Haw, Abhinav Nagulapally, Giselle L Saulnier Sholler
DFMO inhibition of neuroblastoma tumorigenesis. Cancer medicine 13 (9) (2024)
Shumin Fu, Yongkang Xu, Ye Mao, Mengting He, Zhimeng Chen, Shenglan Huang, Dan Li, Yaqin Lv, Jianbing Wu
Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma. Cancer medicine 13 (9) (2024)
Daniel Sanghoon Shin, Saroj Basak, Mysore S Veena, Begoña Comin-Anduix, Arjun Bhattacharya, Tien S Dong, Albert Ko, Philip Han, Jonathan Jacobs, Neda A Moatamed, Luis Avila, Matteo Pellegrini, Marilene Wang, Eri S Srivatsan
Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer. Cancer medicine 13 (9) (2024)
Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis, Anita W Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J Biemond, Arjan A van de Loosdrecht, Lotte E van der Wagen, Mar Bellido, Michel van Gelder, Walter J F M van der Velden, Dominik Selleslag, Daniëlle van Lammeren-Venema, Vincent H J van der Velden, Liesbeth C de Wreede, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling. Cancer medicine 13 (9) (2024)
Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis, Anita W Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J Biemond, Arjan A van de Loosdrecht, Lotte E van der Wagen, Mar Bellido, Michel van Gelder, Walter J F M van der Velden, Dominik Selleslag, Daniëlle van Lammeren-Venema, Vincent H J van der Velden, Liesbeth C de Wreede, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling. Cancer medicine 13 (9) (2024)
Jiaqiang Ren, Shuai Wu, Tong Su, Jiachun Ding, Fan Chen, Jie Li, Zheng Wang, Liang Han, Zheng Wu
Analysis of chemoresistance characteristics and prognostic relevance of postoperative gemcitabine adjuvant chemotherapy in pancreatic cancer. Cancer medicine 13 (9) (2024)
Ines Block, Mark Burton, Kristina P Sørensen, Martin J Larsen, Thi T N Do, Martin Bak, Søren Cold, Mads Thomassen, Qihua Tan, Torben A Kruse
Ensemble-based classification using microRNA expression identifies a breast cancer patient subgroup with an ultralow long-term risk of metastases. Cancer medicine 13 (9) (2024)
Yuanlin Zou, Jicun Zhu, Caijuan Song, Tiandong Li, Keyan Wang, Jianxiang Shi, Hua Ye, Peng Wang
A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population. Cancer medicine 13 (9) (2024)
Adam Khan, Hassan Khan, Griffin K Hughes, Chase Ladd, Ryan McIntire, Brooke Gardner, Andriana M Peña, Abigail Schoutko, Jordan Tuia, Kirstien Minley, Alyson Haslam, Vinay Prasad, Matt Vassar
Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials. Cancer medicine 13 (9) (2024)
Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Yasuharu Kawamoto, Takeru Hirao, Kazuma Daiku, Shingo Maeda, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Sayoko Tsuzaki, Ayumi Ryu, Satoshi Tanada, Shigenori Nagata, Kazuyoshi Ohkawa
Oil blotting paper for formalin fixation increases endoscopic ultrasound-guided tissue acquisition-collected sample volumes on glass slides. Cancer medicine 13 (9) (2024)
Jiaqiang Ren, Shuai Wu, Tong Su, Jiachun Ding, Fan Chen, Jie Li, Zheng Wang, Liang Han, Zheng Wu
Analysis of chemoresistance characteristics and prognostic relevance of postoperative gemcitabine adjuvant chemotherapy in pancreatic cancer. Cancer medicine 13 (9) (2024)
Yuanyuan Yang, Jiayi Zhan, Xiaosheng Li, Jun Hua, Haike Lei, Xiaoliang Chen
A nomogram to predict the risk of venous thromboembolism in patients with colon cancer in China. Cancer medicine 13 (9) (2024)
Yuanlin Zou, Jicun Zhu, Caijuan Song, Tiandong Li, Keyan Wang, Jianxiang Shi, Hua Ye, Peng Wang
A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population. Cancer medicine 13 (9) (2024)
Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Yasuharu Kawamoto, Takeru Hirao, Kazuma Daiku, Shingo Maeda, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Sayoko Tsuzaki, Ayumi Ryu, Satoshi Tanada, Shigenori Nagata, Kazuyoshi Ohkawa
Oil blotting paper for formalin fixation increases endoscopic ultrasound-guided tissue acquisition-collected sample volumes on glass slides. Cancer medicine 13 (9) (2024)
Daniel Sanghoon Shin, Saroj Basak, Mysore S Veena, Begoña Comin-Anduix, Arjun Bhattacharya, Tien S Dong, Albert Ko, Philip Han, Jonathan Jacobs, Neda A Moatamed, Luis Avila, Matteo Pellegrini, Marilene Wang, Eri S Srivatsan
Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer. Cancer medicine 13 (9) (2024)
Shumin Fu, Yongkang Xu, Ye Mao, Mengting He, Zhimeng Chen, Shenglan Huang, Dan Li, Yaqin Lv, Jianbing Wu
Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma. Cancer medicine 13 (9) (2024)
Xiaoyu Hua, Weifeng Feng, Minting Ye, Mingyao Lai, Xiaojun Yu, Mengnan Sun, Juan Li, Ruyu Ai, Yanlin He, Linbo Cai, Changzheng Shi, Xiangning Liu
Development and validation of a nomogram to predict leptomeningeal metastases in lung adenocarcinoma: Cervical lymph node metastasis is an important association factor. Cancer medicine 13 (9) (2024)
Divya Gandra, David H Mulama, David M Foureau, Kimberly Q McKinney, Elizabeth Kim, Kaitlyn Smith, Jason Haw, Abhinav Nagulapally, Giselle L Saulnier Sholler
DFMO inhibition of neuroblastoma tumorigenesis. Cancer medicine 13 (9) (2024)
Daniel Sanghoon Shin, Saroj Basak, Mysore S Veena, Begoña Comin-Anduix, Arjun Bhattacharya, Tien S Dong, Albert Ko, Philip Han, Jonathan Jacobs, Neda A Moatamed, Luis Avila, Matteo Pellegrini, Marilene Wang, Eri S Srivatsan
Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer. Cancer medicine 13 (9) (2024)
Jinliang Ni, Xiaoxiang Yao, Wei Song, Heng Zhang, Houliang Zhang, Yidi Wang, Yifan Zhang, Guangchun Wang, Keyi Wang, Weipu Mao, Bo Peng
Prognostic value of preoperative combined neutrophil, monocyte, and lymphocyte scores in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A retrospective study. Cancer medicine 13 (9) (2024)
Shumin Fu, Yongkang Xu, Ye Mao, Mengting He, Zhimeng Chen, Shenglan Huang, Dan Li, Yaqin Lv, Jianbing Wu
Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma. Cancer medicine 13 (9) (2024)
Gwanwook Bang, Minji Park, Jeong Yeon Seon, So Youn Park
Comparative analysis of genetic testing utilization rates among people with and without disabilities in South Korea from 2016 to 2019, focusing on malignant neoplasms: A national population-based study. Cancer medicine 13 (9) (2024)
Xiaoyu Hua, Weifeng Feng, Minting Ye, Mingyao Lai, Xiaojun Yu, Mengnan Sun, Juan Li, Ruyu Ai, Yanlin He, Linbo Cai, Changzheng Shi, Xiangning Liu
Development and validation of a nomogram to predict leptomeningeal metastases in lung adenocarcinoma: Cervical lymph node metastasis is an important association factor. Cancer medicine 13 (9) (2024)
Amina Banda, Jenneken Naaldenberg, Aura Timen, Agnies van Eeghen, Geraline Leusink, Maarten Cuypers
Cancer risks related to intellectual disabilities: A systematic review. Cancer medicine 13 (9) (2024)
Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Yasuharu Kawamoto, Takeru Hirao, Kazuma Daiku, Shingo Maeda, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Sayoko Tsuzaki, Ayumi Ryu, Satoshi Tanada, Shigenori Nagata, Kazuyoshi Ohkawa
Oil blotting paper for formalin fixation increases endoscopic ultrasound-guided tissue acquisition-collected sample volumes on glass slides. Cancer medicine 13 (9) (2024)
Richard C Maduka, Maureen E Canavan, Samantha L Walters, Theresa Ermer, Peter L Zhan, Michael F Kaminski, Andrew X Li, Matthew D Pichert, Michelle C Salazar, Elizabeth H Prsic, Daniel J Boffa
Association of patient socioeconomic status with outcomes after palliative treatment for disseminated cancer. Cancer medicine 13 (9) (2024)
Lisa Mikesell, Denalee M O'Malley, Rachel T Kurtzman, Jenna Howard, Benjamin Bates, Jennifer R Hemler, Sarah J Fadem, Jeanne M Ferrante, Alicja Bator, Shawna V Hudson, Benjamin F Crabtree
Identifying priority areas to support primary care engagement in breast cancer survivorship care: A Delphi study. Cancer medicine 13 (9) (2024)
Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis, Anita W Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J Biemond, Arjan A van de Loosdrecht, Lotte E van der Wagen, Mar Bellido, Michel van Gelder, Walter J F M van der Velden, Dominik Selleslag, Daniëlle van Lammeren-Venema, Vincent H J van der Velden, Liesbeth C de Wreede, Douwe Postmus, Francesco Pignatti, Jan J Cornelissen
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling. Cancer medicine 13 (9) (2024)
Tracey DiSipio, Cate Scholte, Abbey Diaz
Evaluation of online text-based information resources of gynaecological cancer symptoms. Cancer medicine 13 (9) (2024)
Tracey DiSipio, Cate Scholte, Abbey Diaz
Evaluation of online text-based information resources of gynaecological cancer symptoms. Cancer medicine 13 (9) (2024)